Cosmo Metals Limited (ASX:CMO)

Elevation Oncology Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Selling, General & Admin	0.68	0.57	0.67	0.73
Other Operating Expenses	0.01	0.01	-	-
Operating Expenses	1.46	1.48	0.7	1.32
Operating Income	-1.46	-1.48	-0.7	-1.32
Interest & Investment Income	0.01	0.01	0.01	0
Pretax Income	-1.66	-1.47	-0.69	-1.32
Net Income	-1.66	-1.47	-0.69	-1.32
Net Income to Common	-1.66	-1.47	-0.69	-1.32
Shares Outstanding (Basic)	115	79	51	31
Shares Outstanding (Diluted)	115	79	51	31
Shares Change (YoY)	107.97%	55.84%	66.18%	-
EPS (Basic)	-0.01	-0.02	-0.01	-0.04
EPS (Diluted)	-0.01	-0.02	-0.01	-0.04
Free Cash Flow	-1.47	-1.18	-3.06	-1.96
Free Cash Flow Per Share	-0.01	-0.01	-0.06	-0.06
EBITDA	-0.7	-0.6	-0.68	-1.31
D&A For EBITDA	0.75	0.88	0.02	0
EBIT	-1.46	-1.48	-0.7	-1.32

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.